William Roland Mann Neu Base Therapeutics, Inc. (NBSE) insider trading activity

NBSE Quotes by TradingView

William Roland Mann is Chief Operating Officer of NeuBase Therapeutics, Inc.. Currently has a direct ownership of 11,200 shares of NBSE, which is worth approximately $0. The most recent transaction as insider was on Mar 30, 2022, when has been sold 6,200 shares (Common Stock) at a price of $1.92 per share, resulting in proceeds of $11,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.2K
0% 3M change
0% 12M change
Total Value Held $0

William Roland Mann Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 30 2022
BUY
Open market or private purchase
$11,904 $1.92 p/Share
6,200 Added 35.63%
11,200 Common Stock
Apr 26 2021
BUY
Open market or private purchase
$25,000 $5.0 p/Share
5,000 Added 50.0%
5,000 Common Stock
WRM

William Roland Mann

Chief Operating Officer
Pittsburgh, PA

Track Institutional and Insider Activities on NBSE

Follow NeuBase Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBSE shares.

Notify only if

Insider Trading

Get notified when an Neu Base Therapeutics, Inc. insider buys or sells NBSE shares.

Notify only if

News

Receive news related to NeuBase Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBSE